Kishore Vatsala, Patil Anuradha G
Assistant Professor, Department of Pathology, Heritage Institute of Medical Sciences, Varanasi, Uttar Pradesh, India.
Professor and Head, Department of Pathology, Mahadevappa Rampure Medical College, Kalaburagi, Karnataka, India.
J Clin Diagn Res. 2017 Sep;11(9):EC17-EC20. doi: 10.7860/JCDR/2017/29394.10644. Epub 2017 Sep 1.
Cervical cancer still ranks as the most frequent cancer among women in India. Infection with Human Papilloma Virus (HPV) results in precancerous lesions and invasive cervical cancer. Interaction of HPV oncogenic proteins with cellular regulatory proteins leads to upregulation of p16INK4A, a cyclin dependent kinase inhibitor. Therefore, p16INK4A overexpression is a surrogate biomarker of HPV infection making it useful in evaluating HPV associated premalignant and malignant lesions of gynaecological tract.
This study was conducted to evaluate the usefulness of p16INK4A as a biomarker in dysplastic and malignant alteration of cervical epithelium. A total of 57 specimens diagnosed histopathologically as cervical dysplasia or malignancy were included in this prospective study of two year duration. Immunohistochemical (IHC) study of p16INK4A expression was performed on normal cervical tissue samples, Cervical Intraepithelial Neoplasia (CIN) 1, CIN 2, CIN 3, squamous cell carcinoma, adenocarcinoma. Expression was scored by two methods. One was simple positive versus negative p16INK4A staining and the other method was a semi-quantitative IHC scoring (0 to 8 points) according to the intensity of staining and the proportion of stained cells. The collected data was entered in excel sheet and analysed using Statistical Package For Social Science (SPSS) 16.0 software and the descriptive statistics, Chi-square test. The p-value of <0.05 was considered statistically significant.
Nuclear and/or cytoplasmic p16INK4A immunoreactivity was absent in normal cervical tissue, while immunopositivity was 25% in CIN 1, 50% in CIN 2, 75% in CIN 3, 75% and 100% in squamous cell carcinoma and adenocarcinoma respectively. All normal cervical samples had low scores (0 to 2 points), while number of cases with high scores was proportional to the degree of cervical dysplasia or invasive carcinoma. p16INK4A immunostaining with higher expression (score>5) was observed in 75% cases of carcinoma cervix.
IHC expression of p16INK4A is related to degree of histological dysplasia and malignancy, suggesting its prognostic and predictive value in the management of cervical cancers.
宫颈癌仍是印度女性中最常见的癌症。人乳头瘤病毒(HPV)感染会导致癌前病变和浸润性宫颈癌。HPV致癌蛋白与细胞调节蛋白的相互作用会导致细胞周期蛋白依赖性激酶抑制剂p16INK4A的上调。因此,p16INK4A过表达是HPV感染的替代生物标志物,有助于评估HPV相关的妇科癌前病变和恶性病变。
本研究旨在评估p16INK4A作为宫颈上皮发育异常和恶性改变生物标志物的实用性。在这项为期两年的前瞻性研究中,共纳入了57例经组织病理学诊断为宫颈发育异常或恶性肿瘤的标本。对正常宫颈组织样本、宫颈上皮内瘤变(CIN)1级、CIN 2级、CIN 3级、鳞状细胞癌、腺癌进行了p16INK4A表达的免疫组织化学(IHC)研究。采用两种方法对表达进行评分。一种是简单的p16INK4A染色阳性与阴性,另一种方法是根据染色强度和染色细胞比例进行半定量IHC评分(0至8分)。将收集的数据录入Excel表格,并使用社会科学统计软件包(SPSS)16.0软件进行分析,采用描述性统计和卡方检验。p值<0.05被认为具有统计学意义。
正常宫颈组织中不存在核和/或细胞质p16INK4A免疫反应性,而CIN 1级的免疫阳性率为25%,CIN 2级为50%,CIN 3级为75%,鳞状细胞癌和腺癌分别为75%和100%。所有正常宫颈样本得分较低(0至2分),而高分病例数与宫颈发育异常或浸润癌的程度成正比。在75%的宫颈癌病例中观察到p16INK4A免疫染色表达较高(评分>5)。
p16INK4A的IHC表达与组织学发育异常和恶性程度相关,提示其在宫颈癌管理中的预后和预测价值。